Old Web
English
Sign In
Acemap
>
authorDetail
>
David Preiss
David Preiss
Amgen
Evolocumab
Internal medicine
Medicine
Diabetes mellitus
Cardiology
6
Papers
4
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Metformin: framed again for a crime it didn't commit?
2018
David Preiss
Naveed Sattar
Show All
Source
Cite
Save
Citations (0)
IMPACT OF EVOLOCUMAB THERAPY IN PATIENTS WITH DISCORDANCE BETWEEN LDL-C AND LDL-P
2017
Journal of the American College of Cardiology
Peter P. Toth
Naveed Sattar
Dirk Blom
Seth Martin
Steven R. Jones
Maria Laura Monsalvo
Mary Jane Elliott
Ransi Somaratne
David Preiss
Show All
Source
Cite
Save
Citations (1)
Supplementary material : Effect of Evolocumab on Lipoprotein Particles
2017
Peter P. Toth
Naveed Sattar
Dirk Blom
Seth S. Martin
Steven R. Jones
Maria Laura Monsalvo
Mary Jane Elliott
Michael T. Davis
Ransi Somaratne
David Preiss
Show All
Source
Cite
Save
Citations (0)
A POOLED SAFETY ANALYSIS OF OVER 6000 PATIENTS FROM DOUBLE-BLIND AND OPEN-LABEL EXTENSION STUDIES WITH EVOLOCUMAB
2016
Journal of the American College of Cardiology
Peter P. Toth
Olivier S. Descamps
Jacques Genest
Naveed Sattar
David Preiss
Ricardo Dent
Constantine Djedjos
Yuna Wu
Michelle Geller
Ransi Somaratne
Scott M. Wasserman
Evan A. Stein
Show All
Source
Cite
Save
Citations (3)
1